Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19

The study “Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19” conducted by Alexandra C. Apple et al., provides valuable insights into the cognitive post-acute sequelae of SARS-CoV-2 (PASC), particularly following mild COVID-19 cases. Here is a detailed summary: Study Overview Key Findings Implications and Conclusions Limitations and Future Directions This study contributes significantly to the understanding of cognitive symptoms following mild COVID-19, highlighting the role of pre-existing cognitive risk factors and CSF abnormalities. The insights gained underscore the need for tailored approaches in managing long-term cognitive symptoms in COVID-19 survivors. Read More: https://onlinelibrary.wiley.com/doi/epdf/10.1002/acn3.51498